CT-Guided Transthoracic Needle Biopsy for Evaluation of PD-L1 Expression: Comparison of 22C3 and SP263 Assays

被引：1
|
作者：
Beck, K. [1 ]
Lee, K. Y. [2 ]
Hong, S. J. [3 ]
机构：
[1] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Radiol, Seoul, South Korea
[2] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Pathol, Seoul, South Korea
[3] Hanyang Univ, Guri Hosp, Coll Med, Radiol, Guri, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期
关键词：
CT-guided biopsy; PD-L1; assay;
D O I：
10.1016/j.jtho.2018.08.421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MA13.01
引用
收藏
页码：S399 / S400
页数：2
相关论文
共 50 条
  • [41] Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
    Zhou, Caicun
    Srivastava, Minu K.
    Xu, Hao
    Felip, Enriqueta
    Wakelee, Heather
    Altorki, Nasser
    Reck, Martin
    Liersch, Rudiger
    Kryzhanivska, Anna
    Oizumi, Satoshi
    Tanaka, Hiroshi
    Hamm, John
    McCune, Steven L.
    Bennett, Elizabeth
    Gitlitz, Barbara
    McNally, Virginia
    Ballinger, Marcus
    McCleland, Mark
    Zou, Wei
    Das Thakur, Meghna
    Novello, Silvia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (10)
  • [42] Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263
    Loghin, Andrada
    Nechifor-Boila, Adela
    Borda, Angela
    Nechifor-Boila, Ioan Alin
    Voidazan, Septimiu
    Decaussin-Petrucci, Myriam
    VIRCHOWS ARCHIV, 2022, 480 (02) : 303 - 313
  • [43] Programmed death ligand-1 (PD-L1) immunohistochemical assessment using the QR1 clone in muscle-invasive urothelial carcinomas: a comparison with reference clones 22C3 and SP263
    Andrada Loghin
    Adela Nechifor-Boilă
    Angela Borda
    Ioan Alin Nechifor-Boilă
    Septimiu Voidazan
    Myriam Decaussin-Petrucci
    Virchows Archiv, 2022, 480 : 303 - 313
  • [44] 抗体22C3与SP263检测非小细胞肺癌标本PD-L1水平的一致性比较
    王葆强
    邵琼怡
    孙波
    中国民康医学, 2023, 35 (04) : 138 - 140
  • [45] Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays
    Chapel, David B.
    Stewart, Rachel
    Furtado, Larissa V.
    Husain, Aliya N.
    Krausz, Thomas
    Deftereos, Georgios
    HUMAN PATHOLOGY, 2019, 87 : 11 - 17
  • [46] Comparison of PD-L1 tumor cell expression with 22C3, 28-8, and SP142 IHC assays across multiple tumor types
    Maule, Jake G.
    Clinton, Lani K.
    Graf, Ryon P.
    Xiao, Jinpeng
    Oxnard, Geoffrey R.
    Ross, Jeffrey S.
    Huang, Richard S. P.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [47] Comparison of PD-L1 Immunostain Concordance of SP263 and SP142 Across Different Tumor Types
    Nakasaki, Manando
    Fadare, Oluwole
    Patel, Sandip
    Hansel, Donna
    LABORATORY INVESTIGATION, 2017, 97 : 532A - 532A
  • [48] PD-L1 22C3 and 28-8 Expression in Malignant Mesotheliomas
    Stewart, Rachel
    Chapel, David B.
    Furtado, Larissa
    Husain, Aliya N.
    Krausz, Thomas
    Deftereos, Georgios
    MODERN PATHOLOGY, 2018, 31 : 751 - 751
  • [49] Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.
    Oyan, Basak
    Sonmez, Ozlem
    Yazar, Aziz
    Teomet, Mehmet
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [50] PD-L1 22C3 and 28-8 Expression in Malignant Mesotheliomas
    Stewart, Rachel
    Chapel, David B.
    Furtado, Larissa
    Husain, Aliya N.
    Krausz, Thomas
    Deftereos, Georgios
    LABORATORY INVESTIGATION, 2018, 98 : 751 - 751
12345